
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products include R... Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products include RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs. 더 보기
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.06 | -0.15037593985 | 39.9 | 57.99 | 37.33 | 1739324 | 39.24063122 | CS |
4 | -4.37 | -9.88464148383 | 44.21 | 57.99 | 37.33 | 1323826 | 40.84366942 | CS |
12 | -6.24 | -13.5416666667 | 46.08 | 57.99 | 37.33 | 1335394 | 41.97331623 | CS |
26 | -3.48 | -8.03324099723 | 43.32 | 62.4 | 37.33 | 1421628 | 46.92958718 | CS |
52 | 9.54 | 31.4851485149 | 30.3 | 62.4 | 29.55 | 1403970 | 42.96985451 | CS |
156 | 21.56 | 117.943107221 | 18.28 | 62.4 | 14.08 | 1288768 | 31.18784087 | CS |
260 | 7.39 | 22.7734976888 | 32.45 | 62.4 | 14.08 | 961815 | 31.49191425 | CS |
귀하가 조회한 주식이 이 박스에 나타나며 쉽게 최근 시세로 돌아갈 수 있습니다.
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관